UniProt ID | SPF30_HUMAN | |
---|---|---|
UniProt AC | O75940 | |
Protein Name | Survival of motor neuron-related-splicing factor 30 | |
Gene Name | SMNDC1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 238 | |
Subcellular Localization | Nucleus speckle. Nucleus, Cajal body. Detected in nuclear speckles containing snRNP and in Cajal (coiled) bodies. | |
Protein Description | Necessary for spliceosome assembly. Overexpression causes apoptosis.. | |
Protein Sequence | MSEDLAKQLASYKAQLQQVEAALSGNGENEDLLKLKKDLQEVIELTKDLLSTQPSETLASSDSFASTQPTHSWKVGDKCMAVWSEDGQCYEAEIEEIDEENGTAAITFAGYGNAEVTPLLNLKPVEEGRKAKEDSGNKPMSKKEMIAQQREYKKKKALKKAQRIKELEQEREDQKVKWQQFNNRAYSKNKKGQVKRSIFASPESVTGKVGVGTCGIADKPMTQYQDTSKYNVRHLMPQ | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
7 | Acetylation | -MSEDLAKQLASYKA -CCHHHHHHHHHHHH | 53.81 | 25953088 | |
13 | Ubiquitination | AKQLASYKAQLQQVE HHHHHHHHHHHHHHH | 27.45 | 29967540 | |
37 | Ubiquitination | EDLLKLKKDLQEVIE HHHHHHHHHHHHHHH | 74.28 | 33845483 | |
46 | Phosphorylation | LQEVIELTKDLLSTQ HHHHHHHHHHHHCCC | 15.10 | 25690035 | |
51 | Phosphorylation | ELTKDLLSTQPSETL HHHHHHHCCCCCCCC | 32.09 | 28450419 | |
52 | Phosphorylation | LTKDLLSTQPSETLA HHHHHHCCCCCCCCC | 44.46 | 28450419 | |
55 | Phosphorylation | DLLSTQPSETLASSD HHHCCCCCCCCCCCC | 33.14 | 28450419 | |
57 | Phosphorylation | LSTQPSETLASSDSF HCCCCCCCCCCCCCC | 31.77 | 30576142 | |
60 | Phosphorylation | QPSETLASSDSFAST CCCCCCCCCCCCCCC | 37.48 | 30576142 | |
61 | Phosphorylation | PSETLASSDSFASTQ CCCCCCCCCCCCCCC | 31.50 | 28450419 | |
63 | Phosphorylation | ETLASSDSFASTQPT CCCCCCCCCCCCCCC | 25.35 | 28450419 | |
66 | Phosphorylation | ASSDSFASTQPTHSW CCCCCCCCCCCCCCC | 26.09 | 28450419 | |
67 | Phosphorylation | SSDSFASTQPTHSWK CCCCCCCCCCCCCCE | 34.83 | 28450419 | |
70 | Phosphorylation | SFASTQPTHSWKVGD CCCCCCCCCCCEECC | 20.80 | 28450419 | |
72 | Phosphorylation | ASTQPTHSWKVGDKC CCCCCCCCCEECCEE | 30.94 | 30576142 | |
99 | Ubiquitination | AEIEEIDEENGTAAI EEEEEECCCCCEEEE | 60.05 | 24816145 | |
121 | Ubiquitination | AEVTPLLNLKPVEEG CEEEECCCCEECHHH | 54.42 | 24816145 | |
135 | Phosphorylation | GRKAKEDSGNKPMSK HHCCCCCCCCCCCCH | 45.41 | 26074081 | |
138 | Ubiquitination | AKEDSGNKPMSKKEM CCCCCCCCCCCHHHH | 45.69 | 24816145 | |
141 | Phosphorylation | DSGNKPMSKKEMIAQ CCCCCCCCHHHHHHH | 49.45 | 26074081 | |
142 | 2-Hydroxyisobutyrylation | SGNKPMSKKEMIAQQ CCCCCCCHHHHHHHH | 46.64 | - | |
152 | Phosphorylation | MIAQQREYKKKKALK HHHHHHHHHHHHHHH | 30.23 | 26074081 | |
156 | Ubiquitination | QREYKKKKALKKAQR HHHHHHHHHHHHHHH | 68.76 | 24816145 | |
160 | Ubiquitination | KKKKALKKAQRIKEL HHHHHHHHHHHHHHH | 51.07 | 24816145 | |
165 | Ubiquitination | LKKAQRIKELEQERE HHHHHHHHHHHHHHH | 59.44 | - | |
177 | Ubiquitination | EREDQKVKWQQFNNR HHHHHHHCHHHHHHH | 46.45 | 27667366 | |
184 | Methylation | KWQQFNNRAYSKNKK CHHHHHHHHHCCCCC | 35.69 | 115367587 | |
186 | Phosphorylation | QQFNNRAYSKNKKGQ HHHHHHHHCCCCCCC | 19.55 | 26074081 | |
187 | Phosphorylation | QFNNRAYSKNKKGQV HHHHHHHCCCCCCCE | 28.86 | 26074081 | |
195 | Ubiquitination | KNKKGQVKRSIFASP CCCCCCEEEEEECCC | 32.32 | 24816145 | |
197 | Phosphorylation | KKGQVKRSIFASPES CCCCEEEEEECCCCC | 19.15 | 23403867 | |
201 | Phosphorylation | VKRSIFASPESVTGK EEEEEECCCCCCCCC | 20.60 | 19664994 | |
204 | Phosphorylation | SIFASPESVTGKVGV EEECCCCCCCCCEEC | 28.50 | 30266825 | |
206 | Phosphorylation | FASPESVTGKVGVGT ECCCCCCCCCEECCC | 40.33 | 30266825 | |
208 | Acetylation | SPESVTGKVGVGTCG CCCCCCCCEECCCCC | 26.84 | 25953088 | |
213 | Phosphorylation | TGKVGVGTCGIADKP CCCEECCCCCCCCCC | 12.73 | - | |
219 | Acetylation | GTCGIADKPMTQYQD CCCCCCCCCCCCCCC | 27.89 | 19608861 | |
219 | Ubiquitination | GTCGIADKPMTQYQD CCCCCCCCCCCCCCC | 27.89 | 19608861 | |
222 | Phosphorylation | GIADKPMTQYQDTSK CCCCCCCCCCCCCCC | 32.43 | 28796482 | |
224 | Phosphorylation | ADKPMTQYQDTSKYN CCCCCCCCCCCCCCC | 10.13 | 28796482 | |
227 | Phosphorylation | PMTQYQDTSKYNVRH CCCCCCCCCCCCHHH | 16.16 | 28796482 | |
228 | Phosphorylation | MTQYQDTSKYNVRHL CCCCCCCCCCCHHHC | 41.24 | 28796482 | |
229 | Ubiquitination | TQYQDTSKYNVRHLM CCCCCCCCCCHHHCC | 42.83 | 32015554 | |
229 | Acetylation | TQYQDTSKYNVRHLM CCCCCCCCCCHHHCC | 42.83 | 26051181 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of SPF30_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of SPF30_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of SPF30_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
SF3B3_HUMAN | SF3B3 | physical | 17353931 | |
SF3B2_HUMAN | SF3B2 | physical | 17353931 | |
RL3_HUMAN | RPL3 | physical | 17353931 | |
TSR1_HUMAN | TSR1 | physical | 17353931 | |
EWS_HUMAN | EWSR1 | physical | 17353931 | |
CK5P3_HUMAN | CDK5RAP3 | physical | 17353931 | |
FDFT_HUMAN | FDFT1 | physical | 17353931 | |
SF3A3_HUMAN | SF3A3 | physical | 17353931 | |
SSF1_HUMAN | PPAN | physical | 17353931 | |
MRM3_HUMAN | RNMTL1 | physical | 17353931 | |
SF3B4_HUMAN | SF3B4 | physical | 17353931 | |
RUVB1_HUMAN | RUVBL1 | physical | 17353931 | |
SF3B1_HUMAN | SF3B1 | physical | 17353931 | |
DDX21_HUMAN | DDX21 | physical | 17353931 | |
U520_HUMAN | SNRNP200 | physical | 11331595 | |
PRPF3_HUMAN | PRPF3 | physical | 22365833 | |
NF2IP_HUMAN | NFATC2IP | physical | 26344197 | |
RGAP1_HUMAN | RACGAP1 | physical | 26344197 | |
RBM42_HUMAN | RBM42 | physical | 26344197 | |
RRBP1_HUMAN | RRBP1 | physical | 26344197 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-219, AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-201, AND MASSSPECTROMETRY. | |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-201, AND MASSSPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-201, AND MASSSPECTROMETRY. | |
"A probability-based approach for high-throughput proteinphosphorylation analysis and site localization."; Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.; Nat. Biotechnol. 24:1285-1292(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-201, AND MASSSPECTROMETRY. |